Evidence map›Paper›PMID 40074948›Full record

ArticleNature immunology2025

Tuft cell IL-17RB restrains IL-25 bioavailability and reveals context-dependent ILC2 hypoproliferation.

Xiaogang Feng, Tilde Andersson, Pascal Flüchter, Julia Gschwend, Ivan Berest, Julian L Muff, Antonie Lechner, Aurelia Gondrand, Patrick Westermann, Nina Brander and 10 more

Abstract read
In one paragraph

Article in Nature immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Review
  17. Review
  18. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

20 authors.

Xiaogang Feng *Institute of Physiology, University of Zurich, Zurich, Switzerland.ORCID http://orcid.org/0000-0002-0343-1848
Tilde Andersson *Institute of Physiology, University of Zurich, Zurich, Switzerland.ORCID http://orcid.org/0000-0001-8168-5002
Pascal FlüchterInstitute of Physiology, University of Zurich, Zurich, Switzerland.ORCID http://orcid.org/0000-0002-7279-3383
Julia GschwendInstitute of Physiology, University of Zurich, Zurich, Switzerland.ORCID http://orcid.org/0000-0001-7212-4393
Ivan BerestInstitute of Molecular Health Sciences, ETH Zurich, Zurich, Switzerland.ORCID http://orcid.org/0000-0001-7607-9163
Julian L MuffInstitute of Physiology, University of Zurich, Zurich, Switzerland.ORCID http://orcid.org/0000-0003-2032-7863
Antonie LechnerInstitute of Physiology, University of Zurich, Zurich, Switzerland.ORCID http://orcid.org/0000-0002-1636-3354
Aurelia GondrandInstitute of Physiology, University of Zurich, Zurich, Switzerland.ORCID http://orcid.org/0009-0004-9989-4899
Patrick WestermannPrecision Proteomics Center, Swiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, Davos, Switzerland.ORCID http://orcid.org/0000-0003-2894-6140
Nina BranderInstitute of Physiology, University of Zurich, Zurich, Switzerland.
Daniele CarchidiInstitute of Physiology, University of Zurich, Zurich, Switzerland.
Jeshua C De TenorioInstitute of Physiology, University of Zurich, Zurich, Switzerland.
Tianlang PanInstitute of Physiology, University of Zurich, Zurich, Switzerland.ORCID http://orcid.org/0009-0005-3425-6842
Ulrich BoehmExperimental Pharmacology, Center for Molecular Signaling (PZMS) and Center for Gender-Specific Biology and Medicine (CGBM), Saarland University, Homburg, Germany.
Christoph S N KloseDepartment of Microbiology, Infectious Diseases and Immunology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.ORCID http://orcid.org/0000-0001-8803-2979
David ArtisJill Roberts Institute for Research in Inflammatory Bowel Disease, Weill Cornell Medicine, Cornell University, New York, NY, USA.ORCID http://orcid.org/0000-0002-1753-4100
Christoph B MessnerPrecision Proteomics Center, Swiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, Davos, Switzerland.
Trese Leinders-ZufallCenter for Integrative Physiology and Molecular Medicine, Saarland University, Homburg, Germany.ORCID http://orcid.org/0000-0002-0678-362X
Frank ZufallCenter for Integrative Physiology and Molecular Medicine, Saarland University, Homburg, Germany.ORCID http://orcid.org/0000-0002-4383-8618
Christoph SchneiderInstitute of Physiology, University of Zurich, Zurich, Switzerland. christoph.schneider@uzh.ch.ORCID http://orcid.org/0000-0002-0452-2960

Funding

Regulation of protective immunity following enteric viral infectionU01AI095608 · NIAID · WEILL MEDICAL COLL OF CORNELL UNIV · PI ARTIS, DAVID, SONNENBERG, GREGORY F · 2011 to 2025
$11.0M
Microbiota-derived metabolites and the regulation of host immunity and inflammation (Diversity Supplement)R01AI172027 · NIAID · WEILL MEDICAL COLL OF CORNELL UNIV · PI David Artis, Chun-Jun Guo · 2022 to 2026
$4.4M
Neuroimmune Regulation of Atopic DermatitisR01AR070116 · NIAMS · WASHINGTON UNIVERSITY · PI KIM, BRIAN · 2016 to 2021
$3.8M
Regulation and function of innate lymphoid cells in the gutR01AI095466 · NIAID · WEILL MEDICAL COLL OF CORNELL UNIV · PI ARTIS, DAVID · 2011 to 2022
$3.7M
Neuropeptide-mediated regulation of antihelminth immunityR01AI151599 · NIAID · RUTGERS BIOMEDICAL AND HEALTH SCIENCES · PI ARTIS, DAVID, SIRACUSA, MARK CHRISTOPHER · 2020 to 2024
$3.2M
Neuro-immune regulation of intestinal inflammationR01DK126871 · NIDDK · WEILL MEDICAL COLL OF CORNELL UNIV · PI ARTIS, DAVID · 2020 to 2024
$3.2M
Dietary Regulation of Intestinal Inflammation and RepairR01DK132244 · NIDDK · WEILL MEDICAL COLL OF CORNELL UNIV · PI ARTIS, DAVID, GUO, CHUN-JUN · 2022 to 2025
$2.7M
Deutsche Forschungsgemeinschaft (German Research Foundation) CRC/TRR 241 Project-ID 375876048Deutsche Forschungsgemeinschaft (German Research Foundation) FOR2599 Project-ID 22359157Deutsche Forschungsgemeinschaft (German Research Foundation) Sonderforschungsbereich-Transregio TRR 152Deutsche Forschungsgemeinschaft (German Research Foundation) SPP1937 - KL 2963/3-1 and KL 2963/2-1Deutsche Forschungsgemeinschaft (German Research Foundation) TRR 152NIAID NIH HHS R01 AI095466NIAID NIH HHS R01 AI151599NIAID NIH HHS R01 AI172027NIAID NIH HHS U01 AI095608NIAMS NIH HHS R01 AR070116NIDDK NIH HHS R01 DK126871NIDDK NIH HHS R01 DK132244Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (Swiss National Science Foundation) 194216
6 · The paper itself

Abstract

The tuft cell-group 2 innate lymphoid cell (ILC2) circuit orchestrates rapid type 2 responses upon detecting microbially derived succinate and luminal helminths. Our findings delineate key mechanistic steps involving IP3R2 engagement and Ca

Indexed as

Immunity, InnateInterleukin-17InterleukinsLymphocytesReceptors, Interleukin-17AnimalsHelminthiasisMiceMice, Inbred C57BLMice, KnockoutSuccinic AcidTuft CellsInterleukin-17InterleukinsMydgf protein, mouseReceptors, Interleukin-17Succinic Acid

Identifiers

PMID40074948
PMCPMC11957993

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.